If you have been diagnosed with advanced abdominal/peritoneal cancer, you’ve come to the right place…

HipecTreatment.com

Contact a Surgical Oncologist or Gynecological
Oncologist near you — No referral Needed

Locate a Surgeon

What is HIPEC?

Some types of cancers are very difficult to treat. Cancer that has spread to the lining surfaces of the peritoneal (abdominal) cavity from advanced colon, rectal cancer, ovarian cancer, gastric (stomach) cancer, appendiceal cancer, pseudomyxoma peritonei (PMP) or from primary peritoneal mesothelioma and primary peritoneal cancer–known as peritoneal carcinomatosis–are such cancers.

However, when these cancers are confined to the peritoneal cavity, Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy (HIPEC) becomes an option for candidate patients.

The term “Intraperitoneal” means that the treatment is delivered to the abdominal cavity. The term “Hyperthermic Chemotherapy” means that the solution containing chemotherapy is heated to a temperature greater than normal body temperature.

Before the HIPEC procedure is administered, the surgeon–using standard surgical methods–will remove all visible tumors that can be removed throughout the peritoneal cavity. This is known as cytoreductive surgery. Following cytoreductive surgery, in the operative setting the surgeon will administer the HIPEC Procedure.

Schedule a Call

Schedule a conversation with over 150 Surgical/Gynecological Oncologists in the United States performing Cytoreductive Surgery + HIPEC

Locate a Medical Center

Offering HIPEC

Abdominal Cancers Treated with

Cytoreductive Surgery + HIPEC

Surgical Oncologists and Gynecological Oncologists specialize in treating cancer patients, performing more complex and less common procedures.
Treating advanced abdominal/ peritoneal cancers with Cytoreductive Surgery + HIPEC is a procedure that requires expertise. If you have been diagnosed with advanced abdominal/peritoneal cancer you can schedule a conversation with over 150 Surgical/Gynecological Oncologists in the United States performing Cytoreductive Surgery + HIPEC

Appendix cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) for appendix cancer one potential option for advanced-stage appendix cancer.

Pseudomyxoma Peritonei

Pseudomyxoma peritonei (PMP) is a rare cancer that usually starts in the appendix. When confined to the peritoneal cavity, HIPEC becomes an option.

Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer diagnosed in the United States. HIPEC appears to have promising results when used on elegible patients.

Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface

Peritoneal Mesothelioma

Mesothelioma is a rare and aggressive cancer that occurs in the thin layer of tissue that covers the majority of the internal organs (mesothelium). It is important that patients discuss HIPEC therapy with their oncologists

Primary Peritoneal Cancer

Primary Peritoneal Cancer is a rare cancer that typically affects women. The cells of the peritoneum are very similar to the cells found on the surface of the ovary,

Patient Resources
and Videos

US and International Studies have shown that Cytoreductive Surgery + HIPEC can improve the survival and quality of life for candidate patients. Learn more through out patient resources below: